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Membrane-bound phosphoinositides are signalling molecules
that have a key role in vesicle trafficking in eukaryotic cells1.
Proteins that bind specific phosphoinositides mediate inter-
actions between membrane-bounded compartments whose iden-
tity is partially encoded by cytoplasmic phospholipid tags. Little
is known about the localization and regulation of mammalian
phosphatidylinositol-3,5-bisphosphate (PtdIns(3,5)P2), a phospho-
lipid present in small quantities that regulates membrane traffick-
ing in the endosome–lysosome axis in yeast2. Here we describe a
multi-organ disorder with neuronal degeneration in the central
nervous system, peripheral neuronopathy and diluted pigmenta-
tion in the ‘pale tremor’ mouse. Positional cloning identified in-
sertion of ETn2b (early transposon 2b)3 into intron 18 of Fig4
(A530089I17Rik), the homologue of a yeast SAC (suppressor of
actin) domain PtdIns(3,5)P2 5-phosphatase located in the vacuolar
membrane. The abnormal concentration of PtdIns(3,5)P2 in cul-
tured fibroblasts from pale tremor mice demonstrates the con-
served biochemical function of mammalian Fig4. The cytoplasm
of fibroblasts from pale tremor mice is filled with large vacuoles
that are immunoreactive for LAMP-2 (lysosomal-associated mem-
brane protein 2), consistent with dysfunction of the late endo-
some–lysosome axis. Neonatal neurodegeneration in sensory and
autonomic ganglia is followed by loss of neurons from layers four
and five of the cortex, deep cerebellar nuclei and other localized
brain regions. The sciatic nerve exhibits reduced numbers of large-
diameter myelinated axons, slowed nerve conduction velocity and
reduced amplitude of compound muscle action potentials. We
identified pathogenic mutations of human FIG4 (KIAA0274) on
chromosome 6q21 in four unrelated patients with hereditary
motor and sensory neuropathy. This novel form of autosomal
recessive Charcot–Marie–Tooth disorder is designated CMT4J.
Mutant mice with severe tremor, abnormal gait and diluted pig-
mentation were identified in our mouse colony on a mixed inbred
strain background. One breeding pair generated 8/30 affected pro-
geny, consistent with inheritance of an autosomal recessive muta-
tion designated ‘pale tremor’. At postnatal day three (P3), affected
homozygotes have diluted pigmentation and reduced size (Fig. 1a).
Intentional tremor develops during the second week after birth, and
abnormal limb postures are evident by the third week (Fig. 1b). The
impaired motor coordination, muscle weakness and ‘swimming’ gait
of pale tremor mice are demonstrated in the Supplementary Movie.
There is progressive loss of mobility, reduction in body weight and
juvenile lethality (Fig. 1c).
To genetically map the pale tremor gene, a cross was carried out
with strain CAST/Ei. The recovery of affected F2 offspring was 9%
(50/532), indicative of prenatal loss on this genetic background. We
genotyped 532 F2 animals with microsatellite and single nucleo-
tide polymorphism markers to map the pale tremor gene to a
2-megabase interval of mouse chromosome 10 between D10Umi13
and D10Mit184 (Supplementary Fig. 1a). There are 21 annotated
genes in the non-recombinant interval (http://www.ensembl.org;
mouse build 35); these were tested as candidates by sequencing
reverse transcription polymerase chain reaction (RT–PCR) products
from brain RNA. The A530089I17Rik transcript amplified from pale
tremor RNA lacks exons 19 to 23 from the 39 end of the gene (Fig. 1d).
Hybridization of a polyA1 northern blot with a complementary
DNA probe containing exons 8 to 15 identified a wild-type transcript
of 3.3 kilobases (kb) that is not present in messenger RNA from pale
tremor mice (Fig. 1e). No abnormal transcripts were detected in the
mutant, even when the exposure time was increased from 3 to 63 h
(not shown). We were able to amplify exons 19 to 23 from genomic
DNA, eliminating the possibility of a genomic deletion (Supple-
mentary Fig. 2a).
To identify the genomic mutation, we examined the structure of
intron 18 using PCR. A wild-type product of 0.65 kb and a mutant
product of 6.2 kb were amplified from the 39 end of intron 18 (Fig. 1f).
The sequence of the mutant product (GenBank DQ813648) contains a
5,547 base pair (bp) insert with 99% sequence identity to mouse retro-
transposon ETn2b (GenBank Y17106). The transposon is inserted
384 bp upstream of exon 19, in the same orientation as the gene (Fig.
1h), and is flanked by a duplication of the hexanucleotide CCCCTG,
characteristic of ETn2b insertions3. The mutant allele can be detected by
PCR with a primer in the long terminal repeat (Fig. 1g). The background
strains do not contain the ETn2b element (data not shown), indicating
that mutation of the pale tremor gene is a result of transposon insertion.
The data are consistent with abnormal splicing from exon 18 of Fig4 to
one of the cryptic splice acceptor sites in the ETn2b element3, generating
a transcript of very low abundance that is detected by RT–PCR but is
below the sensitivity of the polyA1 northern blot.
RT–PCR of tissues from wild-type mice demonstrated widespread
expression of Fig4 (Supplementary Fig. 2b), consistent with public
expressed-sequence-tag and microarray databases. In situ hybridi-
zation data demonstrate distribution of the transcript throughout
the brain (http://www.brainatlas.org/aba/ and unpublished observa-
tions, C.Y.C. and M.H.M.). The human orthologue, KIAA0274, is
located on human chromosome 6q21. The mutated protein is most
closely related to the yeast Saccharomyces cerevisiae SAC-domain
phosphatase Fig4, with overall amino acid sequence identity of
35% and similarity of 66%. The SAC domain with the active site
motif CX5R(S/T) is characteristic of phosphatases with specificity
for phosphoprotein or phospholipid substrates4, and exhibits 44%
sequence identity (191/435 amino acids; Supplementary Fig. 1b). The
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four other mammalian genes with SAC domains (SYNJ1, SYNJ2,
INPP5F and SAC1) differ from Fig4 at other domains4, indicating
that mouse A530089I17Rik and human KIAA0274 are homologues of
yeast Fig4.
Yeast Fig4 is localized to the vacuolar membrane and is required
for both generation and turnover of PtdIns(3,5)P2 (ref. 5). Yeast Fig4
exhibits lipid phosphatase activity towards the 5-phosphate resi-
due of PtdIns(3,5)P2 (ref. 6), and also appears to activate the Fab1
kinase that synthesizes PtdIns(3,5)P2 from phosphatidylinositol-3-
phosphate, possibly by dephosphorylating the kinase or one of its
regulators5. As a result, deletion of yeast Fig4 reduces rather than
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Figure 1 | Phenotypes of homozygous pale tremor mice. a, Diluted
pigmentation of the pale tremor mouse (plt) compared with the wild-type
(1/1) mouse. b, Abnormal limb postures. c, Juvenile lethality of F2 mice
from the CAST/Ei cross (n 5 50). d, RT–PCR of Fig4 transcript from brain
with primers in indicated exons. e, Northern blot containing 3 mg of brain
polyA1 RNA, isolated at P7 before extensive neurodegeneration, using a 1 kb
Fig4 cDNA probe (exons 8–15). RNA integrity and equal loading of samples
is indicated by the intensity of minor bands (9–10 kb). f, Long-range PCR of
genomic DNA with primers in intron 18 and exon 19. g, Three-primer
genotyping assay for Fig4 produces 646 bp wild-type and 245 bp Fig4paletremor
products. LTR, long terminal repeat. Molecular weight markers in e–g are
given in kb. h, ETn2b retrotransposon in intron 18 of Fig4. i, Altered
abundance of PtdIns(3,5)P2 in cultured fibroblasts. *Significant difference at
P , 0.05. Data are expressed as mean 6 s.d. (n 5 6).
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leading to defects in vacuole fission, formation of enlarged vacuoles
and impaired retrograde traffic to the late endosome2,8,9. Knockdown
of mammalian Fab1/PIKfyve kinase causes a similar defect in retro-
grade endosome traffic and enlarged vacuoles10.
Analysis of phosphoinositides from cultured fibroblasts of pale
tremor mice demonstrated a three-fold reduction in PtdIns(3,5)P2
(P 5 0.04), with no change in three other phosphoinositides (Fig. 1i).
Enlarged cytoplasmic vacuoles accumulate in 40% of cultured
fibroblasts from pale tremor mice (174/435) compared with 5% of
wild-type cells (22/403) (Supplementary Fig. 3a–d). These vacuoles
stain positively for LAMP-2 (Supplementary Fig. 3e–g), indicating
that they represent late-stage endosomes. The altered levels of
PtdIns(3,5)P2 demonstrate conserved enzymatic function of FIG4
from yeast to mouse, whereas the enlarged vacuoles demonstrate a
conserved cellular role in regulation of the size of late endosomes.
In vivo loss of FIG4 results in a striking pattern of selective neuro-
degeneration. Extensive loss of neurons from sensory and autonomic
ganglia is evident during the neonatal period (Fig. 2a–d and Supple-
mentary Fig. 4a). The presence of neurons with enlarged cytoplasmic
vacuoles suggests that vacuole accumulation precedes cell loss (Fig. 2,
insets). Spinal motor neurons exhibit normal morphology at three
weeks (Fig. 2e–f) but contain vacuoles at six weeks of age (Supple-
mentary Fig. 5).
Peripheral nerves are also affected. Cross-sections of the sciatic
nerve reveal substantial reduction in the number of large-diameter
myelinated axons in the mutant (Fig. 3a, b). Nerve conduction
velocity and amplitude of compound muscle action potentials are
reduced (Fig. 3c, d), consistent with the axonal loss visible in the
sections of the sciatic nerve and the pathological abnormalities in
the motor neurons. There was no response when recording from tail
sensory fibres, consistent with the severe loss of sensory neurons from
the dorsal root ganglia shown in Fig. 2a.
In the brain, neuronal loss in the thalamus, pons, medulla and deep
cerebellar nuclei is visible at one week of age (Supplementary Fig. 6).
By three weeks of age there is additional loss of neurons from layers
four and five of the cortex, the deep layers of the superior and inferior
colliculus and the olfactory bulb (Fig. 2g). Some neuronal cell bodies
contain enlarged vacuoles (Fig. 2h); these vacuoles are not stained by
Oil Red O (for lipid) or periodic acid Schiff (for carbohydrate) (not
shown). Hippocampus, cerebellar cortex and cerebral cortex layers
one, two, three and six remain relatively unaffected throughout the
course of the disease, although under culture conditions hippo-
campal neurons become vacuolated (Supplementary Fig. 4b, c). The
abnormal gait and motor coordination in the pale tremor mutant may
be accounted for by abnormal proprioception owing to degeneration
of dorsal root ganglia neurons, in combination with degeneration of
neurons from brain regions directly involved in motor control (layer
five of the cortex, thalamus and deep cerebellar nuclei).
Abnormalities are visible in skin and spleen. Pigment-containing
hair follicles are greatly reduced in number and the few pigmented
hairs contain clumped melanosomes (Supplementary Fig. 7), similar
to mouse mutants with defects in lysosome–melanosome biogen-
esis11. There is extensive cell loss in the spleen (Supplementary
Fig. 8). White blood cell profiles are normal, and liver, kidney and
testis appear normal when observed by light microscopy.
The clinical and pathological features of peripheral neuropathy in
pale tremor mice resemble some types of Charcot–Marie–Tooth
(CMT) disorder12,13. We tested FIG4 as a candidate gene by screening
95 individuals diagnosed with CMT disorder but lacking mutations
in known genes13. The 23 coding exons of FIG4 were amplified from
genomic DNA, screened by heteroduplex analysis and sequenced.
Patient BAB1079 has a severe, early onset disorder. We identified
the protein truncation mutation F98fsX102 in exon 4 and the mis-
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Figure 2 | Neuropathology in pale tremor mice. a, b, Trigeminal ganglia;
c, d, dorsal root ganglia from lumbar region. Insets reveal cytoplasmic
vacuoles. (Superior cervical ganglia have a similar appearance; see
Supplementary Fig. 4a.) e, f, Spinal cord ventral horn. Arrow, motor neuron
cell body. g, Sagittal section of the brain of a pale tremor mouse (for wild-
type control lacking degeneration see Supplementary Fig. 6). V, enlarged
ventricle. h, Neuronal cell bodies from regions of degeneration in P7 brain.
Scale bars: a–f, 25 mm; insets in a and c, 12.5 mm; panel h, 25 mm.






















































Figure 3 | Pathological abnormalities in peripheral nerves. a, b, Semi-thin
sections of sciatic nerve prepared as described27, demonstrating reduced
density of large-diameter myelinated axons in the pale tremor mutant. Scale
bars, 10 mm. c, d, Reduced sciatic nerve conduction velocity
(mutant, 11.0 6 3.4 m s–1; wild type, 21.5 6 6.3 m s–1) and reduced
amplitude of compound muscle action potentials (mutant, 2.2 6 1.0 mA;
wild type, 5.0 6 2.1 mA) (mean 6 s.d., n 5 6).
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the protein within the SAC domain and is likely to be a loss-of-
function allele. Pedigree analysis demonstrated autosomal recessive
inheritance. Each mutation was inherited from a heterozygous parent
(Fig. 4b). Two heterozygous carriers of F98fsX102 are unaffected,
indicating that FIG4 is not haploinsufficient. Heterozygous pale tre-
mor mice at 18 months of age are also unaffected.
Another patient, BAB1372, was found to be a compound hetero-
zygote with a nonsense mutation R183X in exon 6 together with I41T
(Fig. 4a). R183X was inherited from the patient’s father (Fig. 4b). The
mother is an obligate carrier of I41T, and the patient has an affected
sibling (BAB1373) that also inherited both mutations (Fig. 4b). Both
siblings have severe disease: BAB1372 is functionally quadriplegic
and BAB1373 is wheelchair-bound although retaining normal use
of his arms. Both have slow nerve conduction velocities. A sural nerve
biopsy for BAB1373 demonstrated profound axonal loss, thinly mye-
linated nerve fibres and evidence of de- and re-myelination.
Two additional patients, BAB1161 and BAB1369, carry unique
truncation mutations together with I41T (Fig. 4a). Both patients
developed disease by the age of five and demonstrate reduced nerve
conduction velocity (2–7 m s–1, compared with normal values of 40–
50 m s–1). One patient had motor developmental delay consistent
with Dejerine–Sottas neuropathy.
It is remarkable that four unrelated Caucasian patients carry the same
missense mutation. No additional coding or splice site variants were
detected in these patients when all 23 exons of FIG4 were sequenced.
Isoleucine 41 is located upstream of the SAC phosphatase domain and is
evolutionarily invariant in FIG4 from yeast, invertebrates and verte-
brates (Fig. 4c, d). We sequenced exon 2 from 295 neurologically nor-
mal Caucasian controls but did not identify carriers of this variant. The
observed allele frequencies were 0/590 in controls and 4/190 in CMT
patients (P 5 0.003). The four patients carry I41T on the same 15 kb
haplotype, defined by single nucleotide polymorphisms rs3799845 (G),
rs2025249 (C) and rs7764711 (G) (haplotype frequency 0.29; disequi-
librium coefficient, D9 5 1), consistent with inheritance of a common
ancestral mutant allele (see data in Supplementary Fig. 9). The evidence
suggests that I41T is a rare allele causing partial loss of function that is
pathogenic in combination with a null allele of FIG4.
To assess the functional effect of the I41T allele, we tested the
corresponding mutation (I59T) in yeast. Wild-type and mutant
cDNAs were transformed into the yeast strain fig4D lacking func-
tional Fig4 (ref.7). Transformation with the empty vector did not
correct the enlarged vacuoles in fig4D, which reflects the slightly
reduced levels of PtdIns(3,5)P2 that result from the absence of Fig4
(ref. 7) (Fig. 5a). The vacuolar enlargement was corrected to a com-
parable extent by wild-type and mutant Fig4, indicating that,
under basal conditions, cells expressing Fig4I59T produce normal
levels of PtdIns(3,5)P2 (Fig. 5a). The ability of the mutant to activate
Fab1/PIKfyve kinase was tested by treatment with hyperosmotic
shock as previously described5,7. In cells expressing wild-type Fig4,
hyperosmotic shock produces a transient tenfold increase in intra-
cellular PtdIns(3,5)P2 concentration owing to activation of Fab1/
PIKfyve kinase (Fig. 5b). In cells expressing the mutant, a partial
fourfold increase was observed, demonstrating impaired activation
of Fab1/PIKfyve kinase. It is not clear whether the phosphatase
activity of the mutant is also impaired, owing to the low levels of
PtdIns(3,5)P2.
The data presented here demonstrate that mutation of FIG4 is
responsible for peripheral neuronopathy in human patients. We pro-
pose the designation CMT4J for this disorder, based on the recessive
inheritance pattern. Phosphoinositide signalling has previously been
implicated in CMT disorder types 4B1, 4B2 and 4H (ref. 14–19) (see
Supplementary Discussion). Other genes that function in vesicle
trafficking, such as RAB7A and DNM2 in human20,21 and Vps54 in
mouse22, are associated with inherited neuropathies.
The pale tremor mutant provides the first evidence regarding the
functional role of mammalian Fig4. The results demonstrate a con-
served biochemical function in metabolism of PtdIns(3,5)P2, a con-
served cellular role in regulation of endosomal vesicles, and an
unexpected role in neuronal survival. The molecular basis for the
differential sensitivity of neuronal subtypes to loss of this widely
expressed gene is unclear. Neuronal dependence on FIG4 may be
related to the role of endosomal vesicles in delivering membrane com-
ponents to dendritic spines during long-term potentiation23. The pale
tremor mouse will generate insights into PtdIns(3,5)P2 signalling in

















































Figure 4 | Mutations of FIG4 in patients with CMT disorder. a, Sequencing
chromatographs for four unrelated patients with CMT disorder. Nucleotide
mutations are indicated on the x-axis of each chromatograph numbered
from 11 for the first codon. b, Inheritance of mutant alleles in two pedigrees.
Circle, female; square, male; open symbol, unaffected; filled symbol,
affected. Patient BAB1079 is a compound heterozygote for protein
truncation mutation F98fsX102 and missense mutation I41T. Patients
BAB1372 and BAB1373 are compound heterozygotes for nonsense
mutation R183X and missense mutation I41T. c, Residue isoleucine 41 is
evolutionarily invariant in FIG4 from vertebrates, invertebrates and yeast.
d, Location of CMT mutations in the FIG4 protein. Solid circles, protein
truncation mutations. 907 amino acids are present per protein.
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neurons and provide an animal model for CMT4J and related human
neuropathies.
METHODS SUMMARY
Mutation of the pale tremor gene arose on a mixed background derived from
inbred mouse strains 129/Ola, C57BL/6J, C3H and SJL (ref. 24). The mutant
allele is designated Fig4paletremor. Total RNA was isolated from brain of P7 mice
before extensive neurodegeneration. Primary fibroblasts were cultured from
mouse tail biopsies treated with collagenase. Phosphoinositides were labelled
for 24 h with myo-[2-3H] inositol, extracted and quantified by high-perform-
ance liquid chromatography (HPLC, see Methods). The cohort of unrelated
patients with CMT disorder was previously described13. The 23 coding exons
of FIG4 were screened by heteroduplex analysis25 and products with abnormal
mobility were sequenced. For the four individuals with identified mutations, all
of the other exons were sequenced. Genomic DNA from neurological normal
control individuals was obtained from the Coriell Institute (NDPT006 and
NDPT009, 96 samples each) and from a collection of 111 subjects older than
60 without personal or family history of neurological disease26.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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Figure 5 | Yeast Fig4Ile . Thr is defective in activation of kinase Fab1/
PIKfyve. The fig4D yeast strain lacking endogenous Fig4 (refs 5, 7) was
transformed with empty vector (vector), wild-type myc-Fig4 or myc-Fig4
containing I59T corresponding to human I41T (mutant). a, Yeast were
labelled with FM4-64 to assess vacuole volume, an indicator of basal levels of
PtdIns(3,5)P2. b, Time course of PtdIns(3,5)P2 levels after hyperosmotic
shock (measured in minutes after change to hyperosmotic medium) reflects
activation of Fab1 kinase. The mutant protein exhibits impaired activation
at 10 min compared with the wild type (P 5 0.004; mean 6 s.d., n 5 3). A
western blot demonstrating comparable expression of wild-type and mutant
constructs is presented in Supplementary Fig. 10.
LETTERS NATURE | Vol 448 | 5 July 2007
72
Nature  ©2007 Publishing Group
METHODS
Animals. For genetic mapping, plt/1 heterozygotes were crossed with strain
CAST/Ei (Jackson Laboratory). Experiments were carried out on F2 and F3 mice
from the mapping cross. This research was approved by the University of
Michigan Committee on Use and Care of Animals. Animals were housed and
cared for in accordance with NIH guidelines.
Genotyping and markers. Genotyping was carried out using microsatellite
markers from public databases as well as novel microsatellite markers designed
from mouse genomic sequence (http://www.ensemble.org). D10Umi13 was
amplified with the forward primer 59-CCACCACATCAACAGGCTCACAGG
and the reverse primer 59-AATGCAACCGTGACACAAGTACAC. PCR was car-
ried out with the PCR core kit (Qiagen). PCR products were separated on 6%
acrylamide gels and stained with ethidium bromide. The pale tremor mutation is
genotyped by PCR with a forward primer in intron 18 (59-CGTATGAATT-
GAGTAGTTTTGATG) and two reverse primers, one in the proximal LTR of
the inserted ETn2b element (59-GCTGGGGGAGGGGAGACTACACAG) and
one in exon 19 (59-ATGGACTTGGATCAATGCCAACAG).
RT–PCR. Total RNA was isolated from brain of P7 mice, before extensive neuro-
degeneration. cDNA was synthesized using the First Strand cDNA Synthesis
Kit (Invitrogen). RT–PCR was carried out with the PCR Core Kit (Qiagen).
Long-range PCR was performed with the Expand Long Template PCR System
(Roche). The northern blot with 3mg of polyA1 RNA was prepared as previously
described28. The hybridization probe, a 1 kb RT–PCR product containing exons
8 to 15, was labelled with two radiolabelled nucleotide triphosphates.
Histology. Tissues were sectioned and stained at HistoServ. Fast blue/eosin
staining was carried out in the Department of Pathology, University of
Michigan. Light microscopy was performed on an Olympus BX-51 microscope
and DP50 camera. Sciatic and femoral nerves were sectioned and stained with
osmium for electron microscopy as previously described27. Skin whole mounts
were prepared from P10 mice with the guidance of A. Dlugosz. The commercial
depilatory Nair was applied to the dorsal surface for five minutes followed by
washing with warm water to remove hair. The skin was dissected and superficial
fascia removed. Follicles were visualized on a standard dissecting microscope
with transmitted light.
Neurophysiology. Nerve conduction velocities were recorded from affected pale
tremor mice and littermate controls. Mice were anaesthetized with a ketamine/
xylazine solution and placed under a heating lamp to maintain body temperature
at 32 uC. Recordings were obtained using a Nicolet VikingQuest portable system
and Nicolet disposable EEG needles. Tail sensory responses were obtained by
stimulating proximally over a 3 cm region. Sciatic nerve motor velocities were
obtained by stimulating distally at the sciatic notch and proximally at the knee.
Cell culture and immunofluorescence. Primary fibroblasts were cultured from
mouse tail biopsies treated with collagenase. Cells were plated in DMEM with
10% fetal bovine serum, and maintained at 37 uC with 5% CO2 for up to three
passages. For immunofluorescence, 100,000 cells were seeded on polylysine-
coated cover slips in 35 mm dishes. We thank T. August and the Develop-
mental Studies Hybridoma Bank for monoclonal antibody to LAMP-2,
developed under the auspices of the NICHD and maintained by the Depart-
ment of Biological Sciences, University of Iowa. For labelling with antibody, cells
were fixed with ice-cold methanol at –20 uC for 5 min and blocked with 2% goat
serum. Antibodies were applied for 1 h in PBS with 2% serum at room temper-
ature and detected with Alexa Fluor 488 donkey anti-rabbit (Molecular Probes)
or Alexa Fluor 594 goat anti-rat (Molecular Probes). Cells were visualized on a
DeltaVision Deconvolution microscope system (Applied Precision).
Hippocampal neurons were cultured with glial conditioned media. Neurons
were visualized with a Nikon TE2000 microscope.
Phosphoinositide assays. Fibroblast phosphoinositides were labelled with myo-
[2-3H] inositol, extracted and quantified by HPLC. Mouse fibroblasts from the
first passage were grown in 100 mm dishes to 60–70% confluency. The culture
was rinsed with PBS and starved for 12 h in inositol-free DMEM (Tissue Culture
Support Centre, Washington University) supplemented with 5mg ml–1 transfer-
rin, 5 mg ml–1 insulin and 10% dialysed fetal bovine serum. The medium was
replaced with labelling medium (inositol-free DMEM containing 5mg ml–1
transferrin, 20 mM HEPES and 50 mCi myo-[2-3H] inositol, GE Healthcare).
After 24 h, the culture was treated with 0.6 ml of 4.5% (v/v) perchloric acid for
15 min, scraped off the plate, and spun down at 12,000g for 10 min at 4 uC. The
pellet was washed with 0.1 M EDTA once and resuspended in 50 ml deionized
water. To deacylate the lipids, samples were transferred to a glass vial, mixed with
1 ml methanol/40% methylamine/n-butanol (4:4:1, v/v), and incubated at 55 uC
for 1 h. The resulting samples were vacuum-dried, resuspended in 0.3 ml water
and extracted twice with an equal volume of n-butanol/ethyl ether/formate
(20:4:1, v/v). The aqueous phase was vacuum dried and resuspended in 20 ml
water.
For separation of all isoforms of the glycerophosphoinositides by HPLC, two
different elution gradients were used at 1 ml min–1 flow rate. (Pump A, H2O; pump
B, 1 M (NH4)2HPO4, pH 3.8.) Gradient 1: 0% B for 5 min; 0–2% B over 15 min;
2% B for 80 min; 2–12% B over 20 min; 12% B for 20 min; 12–80% B over 40 min;
80% B for 20 min; 80–0% B over 5 min. To separate glyceroPtdIns(3,4)P2 from
glyceroPtdIns(3,5)P2, a longer gradient (gradient 2) was used: 0% B for 5 min;
0–2% B over 15 min; 2% B for 80 min; 2–10% B over 20 min; 10% B for 65 min; 10–
80% B over 40 min; 80% B for 20 min; 80–0% B over 5 min. The positions of
glyceroPtdIns(3)P, glyceroPtdIns(3,5)P2, glyceroPtdIns(3,4)P2 and glyceroPtdIns
(3,4,5)P3 were determined by
32P-labelled standards received as gifts from L.
Rameh. The positions of glyceroPtdIns(4)P and glyceroPtdIns(4,5)P2 were con-
firmed with yeast glycerophosphoinositide extracts.
Human mutation detection. The cohort of unrelated patients with CMT dis-
order was previously described13. The clinical diagnosis was based on clinical
examination, electrophysiological studies and, in a few cases, nerve biopsy. All
patients received appropriate counselling and gave informed consent approved
by the institutional review board. For the initial screen of FIG4, each coding exon
was amplified and examined by heteroduplex analysis as previously described25.
The patient mutations were identified by sequencing products exhibiting abnor-
mal mobility. Subsequently, the 23 exons of FIG4 were completely sequenced
from the four individuals carrying variants.
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